AzTrials
AzTrials

Post Myocardial InfarctionDREAMNCT01664611

Daily REmote Ischaemic Conditioning Following Acute Myocardial Infarction

A study testing Remote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper arm in people with Post Myocardial Infarction, run by University of Leicester at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Remote ischaemic conditioning (RIC) is known to reduce infarct size post MI when used in the peri/immediate post infarct period. However little is known as to the effect of repeated remote conditioning post-MI (Myocardial Infarction) on not only infarct size, but also on ventricular remodeling and ultimately cardiac… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post Myocardial Infarction
What is being tested?
Remote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper arm
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
90 participants
Where
1 siteUnited Kingdom
Study dates
26 Sep 2012to 30 Oct 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • LVEF < 45% on baseline ECHO
  • First STEMI
  • Successful revascularisation by PPCI
  • Able to attend regional centre for follow-up appointment
  • Competent to consent

Who cannot join

  • < 18 of age
  • ICD or CRTP/D in-situ
  • Prior history of heart failure
  • Haemoglobin < 11.5 g/dl
  • Creatinine > 200 µmol/L (eGFR<30ml/min/m2)
  • Known malignancy/other comorbid condition which in the opinion of the investigator is likely to have significant negative influence on life expectancy
Show all 10Show fewer
  • Significant complications/illness following MI
  • Unable to undergo cMRI
  • Further planned coronary interventions
  • Enrollment in another clinical trial

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Univesrity of Leicester, Department of Cardiovascular Science

    Leicester, Leicestershire, LE3 9QP

Other trials in United Kingdom

About this study

Official title: The DREAM Study (Daily Remote Ischaemic Conditioning Following Acute Myocardial Infarction)

Remote ischaemic conditioning (RIC) is known to reduce infarct size post MI when used in the peri/immediate post infarct period. However little is known as to the effect of repeated remote conditioning post-MI (Myocardial Infarction) on not only infarct size, but also on ventricular remodeling and ultimately cardiac failure. In this phase II first in man trial, the investigators intend to carry out daily remote ischaemic conditioning in post MI patients. The principal hypothesis is that RIC applied on a daily basis for 4 weeks following a heart attack improves the ejection fraction at 4 months as assessed by cardiac magnetic resonance imaging.

Being tested
Remote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper arm, Sham conditioning
Keywords
Remote Ischaemic Conditioning, Remodeling, Heart Failure, Myocardial Infarction, Ischaemia/Reperfusion Injury, successful primary percutaneous coronary intervention following a first STEMI
Medical subject headings
Heart Failure, Myocardial Infarction, Reperfusion Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Remote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper armProcedure or surgery

    Also called The electronic blood pressure cuff used to induce conditioning is the Accoson Greenlight 300., Cell Aegis AutoRIC machine

    Suprasystolic blood pressure cuff inflation for set periods to time to render a limb ischaemic followed by periods of deflation to allow for reperfusion.

  • Sham conditioningProcedure or surgery

    Non therapeutic inflation of a blood pressure cuff that does not cause ischaemia/reperfusion injury

Study groups in NCT01664611
Study groupRoleWhat they receive
Treatment armExperimentalParticipants in this arm will receive remote ischaemic conditioning on a daily basis for 4 weeks post MI
Receives: Procedure: Remote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper arm
Sham armSham comparatorParticipants in this arm will receive sham ischaemic conditioning on a daily basis for 4 weeks post MI
Receives: Procedure: Sham conditioning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean change in LVEF from baseline to 4 months as assessed by cMRI

    Mean change in LVEF from baseline to 4 months as assessed by cMRI

    Measured: Participants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Primary outcome measure assessed at baseline and 4 months post MI.

Secondary outcomes (3)
  1. Final infarct size at 4 months as assessed by cMRI

    Final infarct size at 4 months as assessed by cMRI

    Measured: Participants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Secondary outcome measure assessed at 4 months post MI.

  2. Mean blood biomarker levels of heart failure and ventricular remodelling at baseline and 4 months

    Mean blood biomarker levels of heart failure and ventricular remodelling (e.g. NT-proBNP, MMP9, TIMP1) at baseline and 4 months

    Measured: Participants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Secondary outcome measure assessed at baseline and 4 months post MI.

  3. Mean KCCQ score at 4 months

    Mean Kansas City Cardiomyopathy Screen (KCCQ) score at 4 months

    Measured: Participants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Secondary outcome measure assessed at 4 months post MI.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2012 (estimated)
  2. Study start26 Sep 2012
  3. Primary completion30 Oct 2016
  4. Study completion30 Oct 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01664611
Sponsor's protocol ID
0306
Acronym
DREAM
Status last verified
Aug 2012
First submitted
19 Jul 2012
Last updated
31 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Arnold JR, P Vanezis A, Rodrigo GC, Lai FY, Kanagala P, Nazir S, Khan JN, Ng L, Chitkara K, Coghlan JG, Hetherington S, Samani NJ, McCann GP. Effects of late, repetitive remote ischaemic conditioning on myocardial strain in patients with acute myocardial infarction. Basic Res Cardiol. 2022 Apr 23;117(1):23. doi: 10.1007/s00395-022-00926-7.

    PubMed 35460434
  • Vanezis AP, Arnold JR, Rodrigo G, Lai FY, Debiec R, Nazir S, Khan JN, Ng LL, Chitkara K, Coghlan JG, Hetherington SL, McCann GP, Samani NJ. Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial. Heart. 2018 Dec;104(23):1955-1962. doi: 10.1136/heartjnl-2018-313091. Epub 2018 May 10.

    PubMed 29748420

Questions about this trial

What is this clinical trial studying?

A study testing Remote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper arm in people with Post Myocardial Infarction, run by University of Leicester at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean change in LVEF from baseline to 4 months as assessed by cMRI (time frame: Participants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Primary outcome measure assessed at baseline and 4 months post MI.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01664611, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in